Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1979 Nov;38(3):529–537.

Human serum inhibits the interaction between C1q or rheumatoid factor and IgG-coated latex particles. Reduction of these C1-dependent properties after complement activation in vitro and in vivo

R Hällgren
PMCID: PMC1457841  PMID: 118112

Abstract

The interaction between human C1q or rheumatoid factor (RF) and IgG-coated latex particles was studied by means of standard aggregometer equipment. Fresh normal human serum (NHS) prevented RF from agglutinating such particles (RF-inhibiting activity) and also disagglutinated C1q-induced particle agglutinates (C1q-disagglutinating activity). Strong evidence is presented indicating that C1 was the serum factor responsible for these activities, which were lost after complement activation of serum by IgG aggregates parallel with dissociation of C1. The normal serum range for C1q disagglutinating activity is 68–100% and for RF-inhibiting activity 92–100%. Sera from the majority of patients with systemic lupus erythematosus (SLE) had reduced C1q-disagglutinating activity (78% of the patients) and reduced RF-inhibiting activity (70% of the patients) compared to sera of healthy individuals. Those patients with greatly reduced serum activities as assayed by the present techniques were in the active phase of their disorder as judged from clinical signs and reduced total haemolytic activity. The total complement in CH50 units also correlated significantly (r = 0.73, P<0.001) with the C1q-disagglutinating activity of the patient sera. These findings together with the immunodiffusion pattern against anti-C1q and anti-C1s produced by sera from patients in the active phase of their disease suggested that circulating C1 was present in an activated and sometimes highly activated form among patients with SLE during complement consumption. Based on serial determinations it could also be excluded that functionally defective C1 was inherited or permanent among SLE patients. These techniques, which were supposed to measure functional C1 directly in serum, seemed to be sensitive and reproducible methods suitable for clinical routine in screening pathological sera and it is hoped that the methods will be useful in the treatment of patients with complement consumptive processes.

Full text

PDF
529

Images in this article

533Figure 4
on p.533

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORSOS T., RAPP H. J. CHROMATOGRAPHIC SEPARATION OF THE FIRST COMPONENT OF COMPLEMENT AND ITS ASSAY ON A MOLECULAR BASIS. J Immunol. 1963 Dec;91:851–858. [PubMed] [Google Scholar]
  2. Colten H. R., Borsos T., Rapp H. J. Titration of the first component of complement on a molecular basis: suitability of IgM and unsuitability of IgG hemolysins as sensitizer. Immunochemistry. 1969 May;6(3):461–467. doi: 10.1016/0019-2791(69)90302-4. [DOI] [PubMed] [Google Scholar]
  3. Cooper N. R., Müller-Eberhard H. J. A comparison of methods for the molecular quantitation of the fourth component of human complement. Immunochemistry. 1968 Mar;5(2):155–169. doi: 10.1016/0019-2791(68)90100-6. [DOI] [PubMed] [Google Scholar]
  4. Hällgren R., Stålenheim G., Venge P. Kinetics of the agglutination of IgG-coated latex particles by C1q: the influence of heat-labile serum components. Scand J Immunol. 1979;9(4):365–372. doi: 10.1111/j.1365-3083.1979.tb03175.x. [DOI] [PubMed] [Google Scholar]
  5. Hällgren R., Wide L. Detection of circulating IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus. Ann Rheum Dis. 1976 Aug;35(4):306–313. doi: 10.1136/ard.35.4.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Laurell A. B., Mårtensson U., Sjöholm A. G. Studies of C1 subcomponents in chronic urticaria and angioedema. Int Arch Allergy Appl Immunol. 1977;54(5):434–442. doi: 10.1159/000231859. [DOI] [PubMed] [Google Scholar]
  7. Lizana J., Hellsing K. Polymer enhancement of automated immunological nephelometric analysis, as illustrated by determination of urinary albumin. Clin Chem. 1974 Apr;20(4):415–420. [PubMed] [Google Scholar]
  8. Lurhuma A. Z., Cambiaso C. L., Masson P. L., Heremans J. F. Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq. Clin Exp Immunol. 1976 Aug;25(2):212–226. [PMC free article] [PubMed] [Google Scholar]
  9. Müller-Eberhard H. J. Complement. Annu Rev Biochem. 1969;38:389–414. doi: 10.1146/annurev.bi.38.070169.002133. [DOI] [PubMed] [Google Scholar]
  10. NAFF G. B., PENSKY J., LEPOW I. H. THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT. J Exp Med. 1964 Apr 1;119:593–613. doi: 10.1084/jem.119.4.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nydegger U. E., Lambert P. H., Gerber H., Miescher P. A. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. J Clin Invest. 1974 Aug;54(2):297–309. doi: 10.1172/JCI107765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Yonemasu K., Stroud R. M., Niedermeier W., Butler W. T. Chemical studies of Clq; a modulator of immunoglobulin biology. Biochem Biophys Res Commun. 1971 Jun 18;43(6):1388–1394. doi: 10.1016/s0006-291x(71)80028-1. [DOI] [PubMed] [Google Scholar]
  13. Yonemasu K., Stroud R. M. Structural studies on human Clq: non-covalent and covalent subunits. Immunochemistry. 1972 May;9(5):545–554. doi: 10.1016/0019-2791(72)90064-x. [DOI] [PubMed] [Google Scholar]
  14. Ziccardi R. J., Cooper N. R. Demonstration and quantitation of activation of the first component of complement in human serum. J Exp Med. 1978 Feb 1;147(2):385–395. doi: 10.1084/jem.147.2.385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ziccardi R. J., Cooper N. R. The subunit composition and sedimentation properties of human C1. J Immunol. 1977 Jun;118(6):2047–2052. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES